Session F: Integration of HCV, other Co-Infections and Harm Reduction Services (CHAFEA Sponsored Session)
Tracks
.
| Wednesday, September 19, 2018 |
| 4:15 PM - 5:45 PM |
| Sala XII + XIII |
Speaker
Jean Luc Sion
DG SANTE
What does the EU mean by “integrated” infectious disease programmes and what policy developments have there been to further this agenda?
4:15 PM - 4:20 PMBiography
Mr João Goulão
General Director
SICAD
Mrs Dagmar Hedrich
Consultant
Freelance
Dr Viktor Mravčík
Researcher
National Monitoring Centre For Drugs And Addiction, Office Of The Government, The Czech Republic
Dr John (Jack) Lambert
Consultant In Infectious Diseases, Medicine And Sexual Health (gum)
UCD/ Mater Misericordiae University Hospital Catherine Mc Auley Education & Research Centre, Dublin, Ireland
Alistair Story
E-DETECT
Dr Raquel Duarte
Researcher
Centro De Diagnóstico Pneumológico De Vila Nova De Gaia, Vila Nova Gaia, Portugal
What Does Integration of Services for People who Inject Drugs Mean in Terms of Testing and Providing Treatment? How Does the Health Systems Need to Change to Better Integrate and Can it? Can we Eliminate Hepatitis C Among People Who Inject Drugs on Opioid Substitution Therapy in the Near Future?
5:00 PM - 5:45 PMBiography
Dr John (Jack) Lambert
Consultant In Infectious Diseases, Medicine And Sexual Health (gum)
UCD/ Mater Misericordiae University Hospital Catherine Mc Auley Education & Research Centre, Dublin, Ireland
What does integration of services for PWID mean in terms of testing and providing treatment? How does the health systems need to change to better integrate and can it? Can we eliminate hepatitis C among PWID on opioid substitution therapy in the near future?
5:00 PM - 5:45 PMBiography
Jeffrey Lazarus
What does integration of services for PWID mean in terms of testing and providing treatment? How does the health systems need to change to better integrate and can it? Can we eliminate hepatitis C among PWID on opioid substitution therapy in the near future?
5:00 PM - 5:45 PMBiography
Dr Viktor Mravčík
Researcher
National Monitoring Centre For Drugs And Addiction, Office Of The Government, The Czech Republic
What Does Integration of Services for People who Inject Drugs Mean in Terms of Testing and Providing Treatment? How Does the Health Systems Need to Change to Better Integrate and Can it? Can we Eliminate Hepatitis C Among People Who Inject Drugs on Opioid Substitution Therapy in the Near Future?
5:00 PM - 5:45 PMBiography
Alistair Story
E-DETECT
What Does Integration of Services for People who Inject Drugs Mean in Terms of Testing and Providing Treatment? How Does the Health Systems Need to Change to Better Integrate and Can it? Can we Eliminate Hepatitis C Among People Who Inject Drugs on Opioid Substitution Therapy in the Near Future?
5:00 PM - 5:45 PMBiography
Chair
Jeffrey Lazarus
Associate Research Professor
ISGlobal
Jean Luc Sion
DG SANTE
